Edwards Lifesciences Corp at JPMorgan Healthcare Conference Transcript
Great. Thanks, everyone. If you could take your seats, we can get started. I'm Robbie Marcus, the med tech analyst at JPMorgan. Really happy to bring in our new session with Edwards Lifesciences. I want to introduce CEO, Bernard Zovighian, do a presentation, then we'll join you on stage for Q&A.
Thank you. Thank you, Robbie. Good morning, everyone. We truly value your interest in Edwards. I'm super excited about sharing our vision for 2024 and long term. I'm going to share also a couple of things that happened since our investor conference in December. I'm going to make some forward-looking statements involving risk. They are filed with the SEC and they are on our website. Using non-GAAP financial measure, also same on our website and filed with the SEC.
So as you may have heard at our recent investor conference in December, we are entering a new era of structural heart innovation. So what do we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
